Loading clinical trials...
Loading clinical trials...
Recombinant tPA by Endovascular Administration for the Treatment of Submassive Pulmonary Embolism Using Pharmaco-mechanical Catheter Directed Thrombolysis for the redUction of Thrombus burdEn
Conditions
Interventions
The Bashir™ Endovascular Catheter
r-tPA
Locations
19
United States
UCLA
Los Angeles, California, United States
Miami Cardiac & Vascular Institute
Miami, Florida, United States
Advent Health Orlando
Orlando, Florida, United States
Emory
Atlanta, Georgia, United States
Piedmont Heart Institute
Atlanta, Georgia, United States
Loyola University Chicago
Maywood, Illinois, United States
Start Date
June 23, 2020
Primary Completion Date
June 22, 2022
Completion Date
June 23, 2022
Last Updated
April 20, 2023
NCT06183944
NCT06189313
NCT06166329
NCT06041594
NCT06357403
NCT06451003
Lead Sponsor
Thrombolex, Inc.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions